People | November 22, 2024
Strides Pharma Science appoints Dr. C. Muthulingam as Executive VP - R&D
Dr. Muthu was last associated with Mankind Pharma
Dr. Muthu was last associated with Mankind Pharma
Strides Pharma Science has reported total income of Rs. 1,229.52 crores during the period ended September 30, 2024
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
For the full year FY25, net profit soared 12x to Rs 345 crore
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products
Subscribe To Our Newsletter & Stay Updated
